A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
Table 2
Estimates of variants replication rate relative to wild-type HCV (f) and corresponding predictions of their pre-dosing prevalence.